Twist Bioscience CEO Emily Leproust sells $279,183 in stock
Twist Bioscience CEO Emily Leproust sold 1,687 shares of the company's common stock on September 21, 2026, for a total of $279,183. The shares were sold at $165.491 each and the transaction was executed to cover tax withholding obligations related to the vesting of Restricted Stock Units. The sale of these shares occurred as TWST stock has increased by 579% over the past year, currently trading near its 52-week high of $186.20.
According to InvestingPro analysis, the stock appears to be overvalued at its current level, placing it among companies on the Most Overvalued list.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
